![]() |
|
|
Vol. 293, Issue 3, 996-1001, June 2000
Department of Nuclear Medicine, University Medical Center Nijmegen,
Nijmegen, the Netherlands (P.L., A.H.B., E.Th.M.D., W.J.G., F.H.M.C.,
O.C.B.); Utrecht Institute for Pharmaceutical Science, Utrecht
University, Utrecht, the Netherlands (G.S.); Department of Cell Biology
and Immunology, Faculty of Medicine, Free University, Amsterdam, the
Netherlands (N.v.R.)
This study describes the effect of the lipid dose of
99mTc-polyethylene glycol (PEG) liposomes in the
low-dose range (0.02-1.0 µmol/kg) on the pharmacokinetics and
biodistribution in rats, rabbits, and humans. The biodistribution and
pharmacokinetics of 99mTc-PEG liposomes at various
dose levels were studied in rats and rabbits with a focal
Escherichia coli infection. Scintigraphic images were
recorded on a gamma camera. In addition, the role of macrophages in the
biodistribution of a low-dose PEG liposome injection was studied.
Finally, the pharmacokinetics of 99mTc-PEG liposomes at two
lipid dose levels was studied in four patients. At a dose level of 0.03 µmol/kg, the blood level in rats at 4 h postinjection was
significantly lower than at the highest dose level (1.1 µmol/kg). The
same effect was observed in rabbits where enhanced clearance was
observed at a dose level of 0.02 µmol/kg. The circulatory half-life
decreased from 10.4 to 3.5 h (at 1.0 and 0.02 µmol/kg,
respectively). At the lowest dose level, liposomes were mainly taken up
by the liver and to a lesser extent by the spleen. Injection of a low
dose of PEG liposomes in macrophage-depleted rabbits resulted in normal
pharmacokinetics, suggesting involvement of macrophages in the
effectuation of the rapid elimination of the liposomes from the
circulation. Most importantly, the rapid clearance of low-dose PEG
liposomes was also observed in humans when relatively low lipid doses
were administered. This study showed that at very low lipid doses the
biodistribution of PEG liposomes is dramatically altered.
This article has been cited by other articles:
![]() |
M. L. Schipper, Z. Cheng, S.-W. Lee, L. A. Bentolila, G. Iyer, J. Rao, X. Chen, A. M. Wu, S. Weiss, and S. S. Gambhir microPET-Based Biodistribution of Quantum Dots in Living Mice J. Nucl. Med., September 1, 2007; 48(9): 1511 - 1518. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Awasthi, S.-H. Yee, P. Jerabek, B. Goins, and W. T. Phillips Cerebral oxygen delivery by liposome-encapsulated hemoglobin: a positron-emission tomographic evaluation in a rat model of hemorrhagic shock J Appl Physiol, July 1, 2007; 103(1): 28 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Arnold, D. E. Mager, J. E. Slack, and R. M. Straubinger Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model Clin. Cancer Res., December 15, 2005; 11(24): 8856 - 8865. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sou, R. Klipper, B. Goins, E. Tsuchida, and W. T. Phillips Circulation Kinetics and Organ Distribution of Hb-Vesicles Developed as a Red Blood Cell Substitute J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 702 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. D. Awasthi, D. Garcia, R. Klipper, B. A. Goins, and W. T. Phillips Neutral and Anionic Liposome-Encapsulated Hemoglobin: Effect of Postinserted Poly(ethylene glycol)-distearoylphosphatidylethanolamine on Distribution and Circulation Kinetics J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 241 - 248. [Abstract] [Full Text] |
||||
![]() |
F. A. D. T. G. Wagener, A. Eggert, O. C. Boerman, W. J. G. Oyen, A. Verhofstad, N. G. Abraham, G. Adema, Y. van Kooyk, T. de Witte, and C. G. Figdor Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase Blood, September 15, 2001; 98(6): 1802 - 1811. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Laverman, M. G. Carstens, O. C. Boerman, E. Th. M. Dams, W. J. G. Oyen, N. van Rooijen, F. H. M. Corstens, and G. Storm Factors Affecting the Accelerated Blood Clearance of Polyethylene Glycol-Liposomes upon Repeated Injection J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 607 - 612. [Abstract] [Full Text] [PDF] |
||||